Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
2,884
datasets available to search
ShareScore release 0.9.0
Dataset results
2,884 results for “cancer resistance”
Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer
ClinicalTrials.gov study NCT06619236. IPD Sharing: NO. Countries: 18. Publications: 0.
CJNJ-67652000 and Prednisone for Treatment of Metastatic Castration-Resistant Prostate Cancer and SPOP Gene Mutations
ClinicalTrials.gov study NCT05689021. IPD Sharing: Not stated. Countries: 1. Publications: 0.
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
ClinicalTrials.gov study NCT04868604. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Molecular Characterization of CTCs and ctDNA in Blood and Plasma Samples From Patients With Metastatic and/or Hormone-Resistant Prostate Cancer
ClinicalTrials.gov study NCT02370355. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Monitor the Safety of Enzalutamide in Patients With Progressive Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy
ClinicalTrials.gov study NCT02124668. IPD Sharing: NO. Countries: 2. Publications: 0.
Study on Pembrolizumab in Recurrent, Platinum Resistant, CPS >1 Positive Ovarian, Fallopian Tube and Primary Peritoneal Cancer Patients
ClinicalTrials.gov study NCT04375956. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trastuzumab and Pertuzumab in Combination With Tocilizumab in Subjects With Metastatic HER2 Positive Breast Cancer Resistant to Trastuzumab
ClinicalTrials.gov study NCT03135171. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Phase I Study of HSK46575 in Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT07007910. IPD Sharing: NO. Countries: 1. Publications: 0.
Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency
ClinicalTrials.gov study NCT03442556. IPD Sharing: NO. Countries: 1. Publications: 0.
CABAzitaxel With or Without Prednisone in Patients With Metastatic CAstration REsistant Prostate Cancer Progressed During or After a Previous Docetaxel-based Chemotherapy
ClinicalTrials.gov study NCT03356912. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Evaluation of BAY 59-8862 in Taxane Resistant Non-Small Cell Lung Cancer Patients
ClinicalTrials.gov study NCT00044538. IPD Sharing: Not stated. Countries: 6. Publications: 0.
Inosine Reverse Chemo Resistance in Triple Negative Breast Cancer
ClinicalTrials.gov study NCT06355024. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HC-1119 Versus Enzalutamide in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT03850795. IPD Sharing: NO. Countries: 14. Publications: 0.
Pemetrexed and Gemcitabine for Treatment Resistant Patients With Metastatic Colorectal Cancer and KRAS Mutations
ClinicalTrials.gov study NCT01109615. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Correlative Study of Biomarkers of Resistance in Patients With Castrate Resistant Prostate Cancer Treated With Abiraterone
ClinicalTrials.gov study NCT01857908. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy and Safety of Glumetinib Combined With Osimertinib Mesylate Versus Platinum-based Doublet Chemotherapy in Non-Small Cell Lung Cancer Patients After Resistance to EGFR-
ClinicalTrials.gov study NCT06829459. IPD Sharing: Not stated. Countries: 1. Publications: 0.
LDE225 + Docetaxel/Prednisone for Adv/Met Castrate Resistant Prostate Cancer w/ Disease Progression After Docetaxel
ClinicalTrials.gov study NCT02182622. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Group-Mediated Cognitive Behavioral Resistance Exercise Intervention in Head and Neck Cancer Patients Undergoing Chemoradiation Treatment
ClinicalTrials.gov study NCT04733495. IPD Sharing: NO. Countries: 1. Publications: 0.
XL092 in Patients With Metastatic Castration-Resistant Prostate Cancer
ClinicalTrials.gov study NCT06568562. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Docetaxel Combined with Cirmtuzumab in Metastatic Castration Resistant Prostate Cancer
ClinicalTrials.gov study NCT05156905. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.